ValAsta Astaxanthin Topical Salve 30ml With DMSO
What is astaxanthin, and why does it matter?
Astaxanthin is a red-orange carotenoid produced by the microalga Haematococcus pluvialis under conditions of extreme stress. It is nature's answer to oxidative damage - and it is responsible for the remarkable physical endurance of wild salmon, which cross entire oceans without developing the chronic inflammatory conditions that characterise human ageing.
More than 12 Clinical trials
Meta-analyses now pool over a decade of randomised controlled trial data across inflammation, cognition, eye health, skin and cardiovascular function.
8 years in development
ValAsta's patented glucosidic liposomal delivery system took eight years to perfect - solving the absorption problem that limits every standard astaxanthin capsule.
42 Patents held
Founder Samuel Shepherd is a biochemical engineer and physicist whose patent portfolio spans environmental engineering, carbon capture, and biochemical medicine.
No pro-oxidant rebound
Unlike beta-carotene and some other fat-soluble antioxidants, astaxanthin cannot become pro-oxidant at higher doses. It neutralises free radicals without generating new ones - making it safe for long-term, consistent use.
Crosses the blood-brain barrier
Astaxanthin can cross both the blood-brain and blood-retinal barriers - reaching the neural and ocular tissues where oxidative stress accumulates over decades. This is a property shared by very few natural antioxidants.
Protects mitochondria
Mitochondria - the energy-generating organelles in every cell - are particularly vulnerable to oxidative damage. Astaxanthin accumulates preferentially in mitochondrial membranes, protecting the cellular machinery most critical to energy production and recovery.
What the clinical trials show
Astaxanthin is one of the better-evidenced natural antioxidants in the human clinical trial literature. A decade of randomised controlled trials has now accumulated across multiple independent research groups, with systematic reviews and meta-analyses available for all major health domains.
The evidence is particularly strong for oxidative stress reduction - consistently significant MDA (lipid peroxidation marker) reduction across trials - and for eye health, where multiple RCTs have found preserved visual acuity and reduced screen fatigue in adults over 40. Cognitive, cardiovascular, skin and athletic recovery data are all supported by peer-reviewed RCTs.
It is FDA approved.